Showing results (121-130 of 697) with videos related to
Sort By:
Pageof 70
Expert Review of Anticancer Therapy|July 22, 2015
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphomaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.Expert Review of Hematology|July 4, 2015
Ibrutinib for the treatment of Waldenström macroglobulinemiaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.Mayo Clinic Proceedings|August 14, 2002
Current therapy for multiple myelomaS Vincent Rajkumar, Morie A Gertz, Robert A Kyle, et al.Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.Cancer|February 19, 2008
Thromboembolic events with lenalidomide-based therapy for multiple myelomaSmitha Patiyil Menon, S Vincent Rajkumar, Martha Lacy, et al.Journal of the American Academy of Dermatology|March 29, 2003
Dermatologic side effects of thalidomide in patients with multiple myelomaVirginia C Hall, Rokea A El-Azhary, Saskia Bouwhuis, et al.American Journal of Hematology|May 6, 2009
Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myelomaAlvin C Ng, Shaji K Kumar, S Vincent Rajkumar, et al.Pageof 70